Literature DB >> 34220002

Analysis of Intrinsic and Extrinsic Coagulation Pathway Factors in OCP Treated PCOS Women.

Mohd A Ganie1, Fouzia Rashid2, Saika Manzoor2, Sabhiya Majid3, Iram Shabir3, Iram A Kawa2, Qudsia Fatima2, Humira Jeelani2, Syed Douhath Yousuf2.   

Abstract

Human polycystic ovary syndrome (PCOS)-a cluster of diseases displays various symptoms associated with endocrine and gynecological disorders in childbearing women. Oral contraceptive pills (OCP) being a drug of choice minimizes symptoms and complications associated with the disorder. But, the controversial data available in literature regarding use of OCPs compels us to setup a study design regarding effect of OCP treatment in PCOS subjects and the possible outcomes specifically regarding coagulation pathways. Two PCOS study groups have been selected according to Rotterdam Criteria: one with OCP treatment (n = 50) and other without any drug treatment i.e., drug naive (n = 50). Anthropometry, Biochemistry, Hormones, Insulin and various clotting factors like Factor XI, Factor V, tPA, TAT-III and D-dimer were analyzed in both groups. The results showed worsening of IR, Metabolic parameters and coagulopathy in OCP group comparative to drug naive group indicating adverse effects of the OCP treatment which puts these women at risk for number of future clinical implications especially Cardiovascular and metabolic complications. © Association of Clinical Biochemists of India 2020.

Entities:  

Keywords:  Coagulation pathway; Hyper-coagulability; Insulin resistance; OCP’s; Polycystic ovary syndrome

Year:  2020        PMID: 34220002      PMCID: PMC8215022          DOI: 10.1007/s12291-020-00901-w

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  23 in total

Review 1.  Oral contraceptives and hypercoagulation.

Authors:  Diana B Petitti
Journal:  Clin Adv Hematol Oncol       Date:  2006-11

Review 2.  Effects of VLDL and remnant particles on platelets.

Authors:  Rasaq Olufadi; Christopher D Byrne
Journal:  Pathophysiol Haemost Thromb       Date:  2006

3.  Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies.

Authors:  J Danesh; R Collins; P Appleby; R Peto
Journal:  JAMA       Date:  1998-05-13       Impact factor: 56.272

4.  Postmenopausal hormone replacement therapy increases coagulation activity and fibrinolysis.

Authors:  H J Teede; B P McGrath; J J Smolich; E Malan; D Kotsopoulos; Y L Liang; R E Peverill
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-05       Impact factor: 8.311

Review 5.  Hemodynamic forces in endothelial dysfunction and vascular aging.

Authors:  Caitlin Collins; Ellie Tzima
Journal:  Exp Gerontol       Date:  2010-10-01       Impact factor: 4.032

6.  Estrogen receptor-mediated repression of human hepatic lipase gene transcription.

Authors:  Daniel R Jones; Robert J Schmidt; Richard T Pickard; Patricia S Foxworthy; Patrick I Eacho
Journal:  J Lipid Res       Date:  2002-03       Impact factor: 5.922

7.  Metabolic effects of oral contraceptives in women with polycystic ovary syndrome.

Authors:  M T Korytkowski; M Mokan; M J Horwitz; S L Berga
Journal:  J Clin Endocrinol Metab       Date:  1995-11       Impact factor: 5.958

Review 8.  Estrogens, progestogens and thrombosis.

Authors:  F R Rosendaal; A Van Hylckama Vlieg; B C Tanis; F M Helmerhorst
Journal:  J Thromb Haemost       Date:  2003-07       Impact factor: 5.824

9.  Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women.

Authors:  R S Legro; A R Kunselman; W C Dodson; A Dunaif
Journal:  J Clin Endocrinol Metab       Date:  1999-01       Impact factor: 5.958

10.  Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease.

Authors:  Salim Yusuf; Jackie Bosch; Gilles Dagenais; Jun Zhu; Denis Xavier; Lisheng Liu; Prem Pais; Patricio López-Jaramillo; Lawrence A Leiter; Antonio Dans; Alvaro Avezum; Leopoldo S Piegas; Alexander Parkhomenko; Katalin Keltai; Matyas Keltai; Karen Sliwa; Ron J G Peters; Claes Held; Irina Chazova; Khalid Yusoff; Basil S Lewis; Petr Jansky; Kamlesh Khunti; William D Toff; Christopher M Reid; John Varigos; Gregorio Sanchez-Vallejo; Robert McKelvie; Janice Pogue; Hyejung Jung; Peggy Gao; Rafael Diaz; Eva Lonn
Journal:  N Engl J Med       Date:  2016-04-02       Impact factor: 91.245

View more
  1 in total

1.  Combined Intranasal Insulin/Saxagliptin/Metformin Therapies Ameliorate the Effect of Combined Oral Contraceptive- (COC-) Induced Metabolic Syndrome (MetS) with a Major Target on Glucose Metabolism in Adult Female Wistar Rats.

Authors:  Saheed Olanrewaju Afolabi; Joy Folahan; Olalekan Agede; Olufunke Olorundare
Journal:  Int J Reprod Med       Date:  2021-12-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.